Papers
Topics
Authors
Recent
Search
2000 character limit reached

FH-TabNet: Multi-Class Familial Hypercholesterolemia Detection via a Multi-Stage Tabular Deep Learning

Published 16 Mar 2024 in cs.LG, cs.CV, and eess.IV | (2403.11032v1)

Abstract: Familial Hypercholesterolemia (FH) is a genetic disorder characterized by elevated levels of Low-Density Lipoprotein (LDL) cholesterol or its associated genes. Early-stage and accurate categorization of FH is of significance allowing for timely interventions to mitigate the risk of life-threatening conditions. Conventional diagnosis approach, however, is complex, costly, and a challenging interpretation task even for experienced clinicians resulting in high underdiagnosis rates. Although there has been a recent surge of interest in using Machine Learning (ML) models for early FH detection, existing solutions only consider a binary classification task solely using classical ML models. Despite its significance, application of Deep Learning (DL) for FH detection is in its infancy, possibly, due to categorical nature of the underlying clinical data. The paper addresses this gap by introducing the FH-TabNet, which is a multi-stage tabular DL network for multi-class (Definite, Probable, Possible, and Unlikely) FH detection. The FH-TabNet initially involves applying a deep tabular data learning architecture (TabNet) for primary categorization into healthy (Possible/Unlikely) and patient (Probable/Definite) classes. Subsequently, independent TabNet classifiers are applied to each subgroup, enabling refined classification. The model's performance is evaluated through 5-fold cross-validation illustrating superior performance in categorizing FH patients, particularly in the challenging low-prevalence subcategories.

Definition Search Book Streamline Icon: https://streamlinehq.com
References (20)
  1. “Familial Hypercholesterolemia: Pitfalls and Challenges in Diagnosis and Treatment,” Reviews in Cardiovascular Medicine, 2023.
  2. “Familial Hypercholesterolemia Prevalence Among Ethnicities-Systematic Review and Meta-Analysis,” Front Genet, 2022.
  3. C. Müller, “Xanthomata, Hypercholesterolemia, Angina pectoris”, Acta Medica Scandinavica, 1938.
  4. World Health Organization, “Familial hypercholesterolaemia (FH): Report of a Second WHO Consultation 1998,” https://apps.who.int/iris/handle/10665/66346.
  5. “Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society,” European Heart Journal, 2013.
  6. “The genetics and screening of familial hypercholesterolaemia,” Biomed Sci, 2016.
  7. “Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC),” The Lancet, 2021.
  8. “Clinical Genetic Testing for Familial Hypercholesterolemia,” Journal of the American College of Cardiology, 2018.
  9. O. Najam, and K. K. Ray, “Familial Hypercholesterolemia: a Review of the Natural History, Diagnosis, and Management,” Cardiol Ther, 2015.
  10. “Mapping of familial hypercholesterolemia and dyslipidemias basic management infrastructure in Pakistan: a cross-sectional study,” Lancet Reg Health Southeast Asia, 2023.
  11. “Tabnet: Attentive interpretable tabular learning,” AAAI conference on artificial intelligence, 2021.
  12. “Familial Hypercholesterolaemia Diagnosis and Management,” Eur Cardiol, 2023.
  13. K.D. Myers, at al., “Precision Screening for Familial Hypercholesterolaemia: A Machine Learning Study Applied to Electronic Health Encounter Data,” The Lancet Digital Health, 2019.
  14. “A Machine Learning Model to Aid Detection of Familial Hypercholesterolemia,” JACC: Advances, 2023.
  15. “Finding Missed Cases of Familial Hypercholesterolemia in Health Systems using Machine Learning,” NPJ Digit. Med., 2019.
  16. “Performance and Clinical Utility of Supervised Machine-Learning Approaches in Detecting Familial Hypercholesterolaemia in Primary Care,” NPJ Digit. Med., 2020.
  17. P. Moradifar, M.M. Amiri, “Prediction of Hypercholesterolemia using Machine Learning Techniques,” J. Diabetes Metab. Disord., 2023.
  18. “Applications of machine learning in familial hypercholesterolemia,” Front Cardiovasc Med, 2023.
  19. E. Dritsas, M. Trigka, “Machine Learning Methods for Hypercholesterolemia Long-Term Risk Prediction,” Sensors, 2022.
  20. “Criteria for Diagnosis of Familial Hypercholesterolemia: A Comprehensive Analysis of the Different Guidelines, Appraising their Suitability in the Omani Arab Population,” Oman Med, 2014.

Summary

Whiteboard

No one has generated a whiteboard explanation for this paper yet.

Open Problems

We haven't generated a list of open problems mentioned in this paper yet.

Continue Learning

We haven't generated follow-up questions for this paper yet.

Collections

Sign up for free to add this paper to one or more collections.

Tweets

Sign up for free to view the 1 tweet with 0 likes about this paper.